Risk factors for acute renal injury in living donor liver transplantation: evaluation of the RIFLE criteria
Masashi Utsumi(Okayama University), Toshiyoshi Fujiwara(Okayama University), Hiroaki Matsuda(Okayama University), Daisuke Satoh(Okayama University), Daisuke Nobuoka(Fukuyama City Hospital), Takeshi Nagasaka(Okayama University), Akinobu Takaki(Okayama University), Susumu Shinoura(Okayama University), Takahito Yagi(Okayama University), Hiroshi Sadamori(Okayama University), Yuzo Umeda(Okayama University), Tomokazu Fuji(Okayama University), Ryuichi Yoshida(Okayama University)
Cited by 92
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
|OncoImmunology|2016|178